Sprout’s female libido drug Addyi back in FDA’s crosshairs years after controversial approval
Sprout’s female libido drug Addyi back in FDA’s crosshairs years [...]
Sprout’s female libido drug Addyi back in FDA’s crosshairs years [...]
So far, so not-so-good: Neurologists slow to warm up to [...]
Sanofi, Lilly, Novo and a trio of PBMs face racketeering [...]
Florida judge rules for generic, over-the-counter manufacturers of Zantac knockoffs, [...]
Seagen, Astellas’ Padcev snares full approval and expands into second-line [...]
Bayer’s Farxiga rival Kerendia scores long-awaited kidney and heart disease [...]